Trials / Unknown
UnknownNCT05822115
Reduction of Breast Hypertrophy by Means of Coelioscopique Surgery
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 5 (estimated)
- Sponsor
- Groupe Hospitalier Nord-Essonne · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The objective of this interventional study is based on the hypothesis that coelioscopique surgery could be used to reduce breast hypertrophy. This study can be expected to scientifically validate the use of laparoscopic surgery to obtain a clinical result in the context of reduction of medium volume breast hypertrophy.
Detailed description
Breast reductions are common procedures. One of the main difficulties related to this surgery remains the healing, wide at the peri-areolar level, vertical at the sub-areolar level and in the sub-mammary fold. In addition, this intervention remains subject to the vagaries of hypertrophic or even keloidal healing, especially in young subjects. On This study can be expected to scientifically validate the use of laparoscopic surgery to obtain a clinical result without scarring in the context of the reduction of medium volume breast hypertrophy. Ultimately, the results of this study may serve as a basis for further research by proposing: * Prophylactic mastectomies and immediate breast reconstruction without lateral scar and with a less visible sub-breast scar. * A breast reduction in young patients before the skin undergoes the effects of the heaviness of the breasts.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Reduction of breast hypertrophy by means of laparoscopic | The research procedure is a breast reduction performed by means of laparoscopic surgery. The project consists of removing a disc from the breast at the level of the base, thus causing peripheral skin slackening of 2 to 3 cm but circular. Both breasts are usually operated on at the same time. In case of asymmetry, only one side will be treated. |
Timeline
- Start date
- 2023-04-24
- Primary completion
- 2024-09-01
- Completion
- 2024-09-01
- First posted
- 2023-04-20
- Last updated
- 2023-05-09
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05822115. Inclusion in this directory is not an endorsement.